HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tetsuya Yamamoto Selected Research

Antibodies

12/2020Current Trends and Future Prospects of Molecular Targeted Therapy in Head and Neck Squamous Cell Carcinoma.
7/2015Diagnostic advantage of double immunohistochemistry using two mutation-specific anti-IDH antibodies (HMab-1 and MsMab-1) in gliomas.
9/2010A prospective analysis of anti-desmoglein antibody profiles in patients with rheumatoid arthritis treated with thiol compounds.
6/2010A case of ATLL (adult T-cell leukemia/lymphoma) mimicking odontogenic infection.
11/2005Inhibition of autoantigen expression by (-)-epigallocatechin-3-gallate (the major constituent of green tea) in normal human cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tetsuya Yamamoto Research Topics

Disease

98Neoplasms (Cancer)
05/2024 - 01/2002
32Glaucoma
03/2024 - 01/2002
28Glioma (Gliomas)
10/2023 - 07/2009
25Hyperuricemia
03/2024 - 01/2004
25Glioblastoma (Glioblastoma Multiforme)
01/2023 - 08/2007
21Gout
01/2021 - 07/2002
19Open-Angle Glaucoma (Glaucoma, Open Angle)
03/2024 - 01/2002
16Brain Neoplasms (Brain Tumor)
01/2023 - 01/2002
15Insulin Resistance
01/2023 - 06/2005
13Squamous Cell Carcinoma of Head and Neck
05/2024 - 01/2003
13Low Tension Glaucoma
01/2020 - 01/2002
12Body Weight (Weight, Body)
01/2021 - 04/2002
11Infections
07/2023 - 10/2009
11Blister (Bulla)
01/2021 - 01/2009
10Inflammation (Inflammations)
01/2024 - 11/2005
8Ocular Hypertension (Glaucoma, Suspect)
03/2024 - 06/2007
8Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2021 - 02/2003
8Hypoxia (Hypoxemia)
01/2019 - 07/2005
7Aneurysm (Aneurysms)
04/2024 - 06/2017
7Carcinoma (Carcinomatosis)
04/2021 - 01/2003
6Pathologic Constriction (Stenosis)
12/2023 - 11/2007
6Stroke (Strokes)
10/2023 - 01/2010
6Atherosclerosis
09/2023 - 01/2004
6Hemorrhage
06/2022 - 08/2005
6Type 2 Diabetes Mellitus (MODY)
01/2022 - 05/2003
6Lymphoma (Lymphomas)
07/2021 - 06/2010
6Mouth Neoplasms (Oral Cancer)
08/2020 - 09/2004
5Chronic Renal Insufficiency
03/2024 - 01/2014
5Ischemic Stroke
12/2023 - 01/2017
5Astrocytoma (Pilocytic Astrocytoma)
01/2023 - 04/2011
5Epilepsy (Aura)
01/2022 - 01/2021
5Disease Progression
04/2021 - 11/2007
5Ganglion Cysts (Ganglion)
01/2020 - 10/2004
5Necrosis
07/2018 - 09/2003
4Paralysis (Palsy)
11/2023 - 10/2015
4Ischemia
10/2023 - 09/2003
4Obesity
01/2022 - 06/2005
4Neoplasm Metastasis (Metastasis)
12/2020 - 01/2011
4Breast Neoplasms (Breast Cancer)
11/2018 - 07/2002
4Brain Edema (Cerebral Edema)
07/2017 - 01/2009

Drug/Important Bio-Agent (IBA)

37Uric Acid (Urate)IBA
03/2024 - 04/2002
18Proteins (Proteins, Gene)FDA Link
11/2023 - 07/2002
17Retinaldehyde (Retinal)IBA
01/2020 - 01/2002
12purineIBA
01/2023 - 09/2003
12Temozolomide (Temodar)FDA LinkGeneric
01/2021 - 01/2010
11Insulin (Novolin)FDA Link
01/2023 - 06/2008
10Reactive Oxygen Species (Oxygen Radicals)IBA
01/2021 - 10/2003
10Mitomycin (Mitomycin-C)FDA LinkGeneric
11/2016 - 06/2002
10Xanthine OxidaseIBA
12/2014 - 09/2003
9Glucose (Dextrose)FDA LinkGeneric
01/2022 - 04/2012
9FebuxostatFDA Link
12/2018 - 06/2011
9Allopurinol (Remid)FDA LinkGeneric
06/2011 - 07/2002
8K-115IBA
03/2024 - 10/2013
8TeaIBA
05/2014 - 07/2003
8PolyphenolsIBA
05/2014 - 07/2003
7Cancer VaccinesIBA
01/2023 - 08/2007
7Formaldehyde (Formol)FDA Link
01/2023 - 07/2002
6Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2023 - 01/2012
6CytokinesIBA
10/2021 - 01/2003
6SodiumIBA
05/2021 - 06/2004
6Messenger RNA (mRNA)IBA
01/2021 - 03/2005
6Biomarkers (Surrogate Marker)IBA
12/2020 - 03/2011
6Bevacizumab (Avastin)FDA Link
07/2018 - 01/2013
6AntioxidantsIBA
01/2017 - 01/2003
6UridineIBA
06/2010 - 04/2002
5SteroidsIBA
03/2023 - 01/2013
5BoronIBA
01/2023 - 04/2008
5rho-Associated KinasesIBA
01/2023 - 10/2013
5AntibodiesIBA
12/2020 - 11/2005
5Peptides (Polypeptides)IBA
06/2019 - 11/2004
5Latanoprost (Xalatan)FDA Link
11/2016 - 01/2006
5Carmustine (FIVB)FDA Link
07/2016 - 11/2013
5HypoxanthineIBA
01/2015 - 09/2003
5epigallocatechin gallate (epigallocatechin-3-gallate)IBA
05/2014 - 07/2003
5AutoantibodiesIBA
07/2011 - 01/2004
4ErbB Receptors (EGF Receptor)IBA
05/2024 - 08/2014
4Lactic Acid (Lactate)FDA LinkGeneric
01/2024 - 06/2005
4LipidsIBA
09/2023 - 05/2010
4ParaffinIBA
01/2023 - 07/2002
4DNA (Deoxyribonucleic Acid)IBA
01/2023 - 05/2005
4Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
01/2021 - 04/2011
4Ethanol (Ethyl Alcohol)IBA
10/2018 - 10/2002
4VaccinesIBA
01/2018 - 08/2007

Therapy/Procedure

60Therapeutics
03/2024 - 01/2003
35Radiotherapy
07/2023 - 10/2003
23Drug Therapy (Chemotherapy)
04/2022 - 10/2006
16Trabeculectomy (Trabeculoplasty)
01/2021 - 04/2006
9Chemoradiotherapy
01/2023 - 03/2003
9Boron Neutron Capture Therapy
01/2023 - 11/2004
8Proton Therapy
11/2021 - 03/2014
6Thrombectomy
12/2023 - 01/2017
6Lasers (Laser)
01/2022 - 01/2002
6Filtering Surgery
01/2021 - 09/2007
5Decompression
11/2023 - 10/2018
5Immunotherapy
07/2017 - 01/2003
4Operative Surgical Procedures
04/2024 - 01/2019
4Catheters
01/2024 - 11/2007
4Arthroplasty
10/2023 - 08/2019
4Craniotomy
07/2023 - 10/2015
4Aftercare (After-Treatment)
01/2023 - 08/2009